What is Boundless Bio, Inc. Common Stock's Market Cap?

Boundless Bio, Inc. Common Stock's Market Cap is $66.2M, based on as-reported figures from SEC (XBRL) filings.

What is Boundless Bio, Inc. Common Stock's Enterprise Value?

Boundless Bio, Inc. Common Stock's Enterprise Value is -$6.4M, based on as-reported figures from SEC (XBRL) filings.

What is Boundless Bio, Inc. Common Stock's EV / EBITDA?

Boundless Bio, Inc. Common Stock's EV / EBITDA is 0.1×, based on as-reported figures from SEC (XBRL) filings.

What is Boundless Bio, Inc. Common Stock's Net Income (TTM)?

Boundless Bio, Inc. Common Stock's Net Income (TTM) is -$64.0M, based on as-reported figures from SEC (XBRL) filings.

What is Boundless Bio, Inc. Common Stock's EBITDA?

Boundless Bio, Inc. Common Stock's EBITDA is -$65.9M, based on as-reported figures from SEC (XBRL) filings.

What is Boundless Bio, Inc. Common Stock's Diluted EPS (TTM)?

Boundless Bio, Inc. Common Stock's Diluted EPS (TTM) is -2.81, based on as-reported figures from SEC (XBRL) filings.

What is Boundless Bio, Inc. Common Stock's Net Debt?

Boundless Bio, Inc. Common Stock's Net Debt is -$72.6M, based on as-reported figures from SEC (XBRL) filings.

Boundless Bio, Inc. Common Stock (BOLD) Financial Statements

Boundless Bio, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00Q4W34V1

XNAS · usd

2.91▲ 0.05 (1.75%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close2.86

Day's Range2.76 – 2.94

52-Week Range0.96 – 3.16

Volume167.2K

Avg Volume196.7K

Share Statistics

Shares Outstanding

Employees—

ExchangeXNAS

Listed2024-03-28

Share count as of August 5, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Boundless Bio, Inc. Common Stock (BOLD)

What is Boundless Bio, Inc. Common Stock's Market Cap?: Boundless Bio, Inc. Common Stock's Market Cap is $66.2M, based on as-reported figures from SEC (XBRL) filings.
What is Boundless Bio, Inc. Common Stock's Enterprise Value?: Boundless Bio, Inc. Common Stock's Enterprise Value is -$6.4M, based on as-reported figures from SEC (XBRL) filings.
What is Boundless Bio, Inc. Common Stock's EV / EBITDA?: Boundless Bio, Inc. Common Stock's EV / EBITDA is 0.1×, based on as-reported figures from SEC (XBRL) filings.
What is Boundless Bio, Inc. Common Stock's Net Income (TTM)?: Boundless Bio, Inc. Common Stock's Net Income (TTM) is -$64.0M, based on as-reported figures from SEC (XBRL) filings.
What is Boundless Bio, Inc. Common Stock's EBITDA?: Boundless Bio, Inc. Common Stock's EBITDA is -$65.9M, based on as-reported figures from SEC (XBRL) filings.
What is Boundless Bio, Inc. Common Stock's Diluted EPS (TTM)?: Boundless Bio, Inc. Common Stock's Diluted EPS (TTM) is -2.81, based on as-reported figures from SEC (XBRL) filings.
What is Boundless Bio, Inc. Common Stock's Net Debt?: Boundless Bio, Inc. Common Stock's Net Debt is -$72.6M, based on as-reported figures from SEC (XBRL) filings.